General Assembly Raised Bill No. 962
January Session, 2017 LCO No. 4722
*_____SB00962CE____032117____*
Referred to Committee on COMMERCE
Introduced by:
(CE)
General Assembly
Raised Bill No. 962
January Session, 2017
LCO No. 4722
*_____SB00962CE____032117____*
Referred to Committee on COMMERCE
Introduced by:
(CE)
AN ACT CONCERNING THE DEVELOPMENT OF EVALUATIVE METRICS FOR BIOSCIENCE INVESTMENTS IN THE STATE.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. (Effective from passage) Connecticut Innovations, Incorporated shall contract with a private vendor to develop, not later than January 1, 2018, a set of metrics to evaluate the relationship between the state's investments in bioscience and the economic outcomes resulting from such investments, including, but not limited to, increased employment and any multiplier effects. Not later than thirty days after the development of such metrics is completed, Connecticut Innovations, Incorporated shall, in accordance with the provisions of section 11-4a of the general statutes, submit a report on the metrics developed pursuant to this section to the joint standing committee of the General Assembly having cognizance of matters relating to commerce.
This act shall take effect as follows and shall amend the following sections:
Section 1 from passage New section
This act shall take effect as follows and shall amend the following sections:
Section 1
from passage
New section
CE Joint Favorable
CE
Joint Favorable